Fmr LLC Biotechnology

Fmr LLC

$1.49 Trillion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CABA Cabaletta Bio, Inc.	$49.3M	$5,000 0.0% of portfolio	4,161	Q1 2025 Reduced 89.67%
HUMA Humacyte, Inc.	$249M	$5,000 0.0% of portfolio	3,241	Q1 2025 Reduced 87.33%
CVAC Cure Vac N.V.	$1.01B	$4,000 0.0% of portfolio	1,600	Q1 2025 New
GLSI Greenwich Life Sciences, Inc.	$158M	$4,000 0.0% of portfolio	463	Q1 2025 Added 240.44%
SCPH Sc Pharmaceuticals Inc.	$133M	$4,000 0.0% of portfolio	1,705	Q1 2025 Reduced 73.5%
HOWL Werewolf Therapeutics, Inc.	$41.3M	$4,000 0.0% of portfolio	4,461	Q1 2025 Added 143.64%
BOLT Bolt Biotherapeutics, Inc.	$210M	$3,000 0.0% of portfolio	8,100	Q1 2025 Reduced 93.73%
ELEV Elevation Oncology, Inc.	$8.62M	$3,000 0.0% of portfolio	11,983	Q1 2025 Reduced 27.12%
FGEN Fibrogen Inc	$756M	$3,000 0.0% of portfolio	10,430	Q1 2025 Reduced 97.48%
KRON Kronos Bio, Inc.	$50M	$3,000 0.0% of portfolio	4,600	Q4 2024 Added 21.05%
PDSB Pds Biotechnology Corp	$34.2M	$3,000 0.0% of portfolio	2,778	Q1 2025 Added 227.98%
PROK Prokidney Corp Ord Shs Cl A(Cy	$41.2M	$3,000 0.0% of portfolio	4,348	Q1 2025 Reduced 34.53%
SPRO Spero Therapeutics, Inc.	$85.6M	$3,000 0.0% of portfolio	5,056	Q1 2025 Added 17.88%
TERN Terns Pharmaceuticals, Inc.	$213M	$3,000 0.0% of portfolio	1,362	Q1 2025 Reduced 98.8%
THRD Third Harmonic Bio, Inc.	$219M	$3,000 0.0% of portfolio	1,066	Q1 2025 Reduced 99.96%
XBIT X Biotech Inc.	$91.3M	$3,000 0.0% of portfolio	946	Q1 2025 Reduced 97.09%
BCYC Bicycle Therapeutics PLC	$239M	$2,000 0.0% of portfolio	316	Q4 2024 Reduced 99.79%
LRMR Larimar Therapeutics, Inc.	$144M	$2,000 0.0% of portfolio	1,312	Q1 2025 Reduced 97.03%
VERU Veru Inc.	$48.9M	$2,000 0.0% of portfolio	5,112	Q1 2025 Reduced 37.83%
RPTX Repare Therapeutics Inc.	$63.7M	$1,000 0.0% of portfolio	1,600	Q1 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	990,860	Q1 2025 Reduced 10.1%
CGTX Cognition Therapeutics Inc	$15.7M	$0 0.0% of portfolio	1	Q3 2024 Reduced 99.01%
CRVS Corvus Pharmaceuticals, Inc.	$200M	$0 0.0% of portfolio	5	Q4 2024 Reduced 50.0%
ELDN Eledon Pharmaceuticals, Inc.	$51.6M	$0 0.0% of portfolio	17	Q1 2024 New
ETON Eton Pharmaceuticals, Inc.	$364M	$0 0.0% of portfolio	10	Q1 2025 New
GANX Gain Therapeutics, Inc.	$18.9M	$0 0.0% of portfolio	80	Q1 2025 New
NERV Minerva Neurosciences, Inc.	$10.6M	$0 0.0% of portfolio	25	Q1 2025 New
PMCB Pharma Cyte Biotech, Inc.	$22M	$0 0.0% of portfolio	6	Q1 2025 New
PMVP Pmv Pharmaceuticals, Inc.	$60.7M	$0 0.0% of portfolio	315	Q1 2025 Reduced 68.66%
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	50	Q1 2025 New
RVPH Reviva Pharmaceuticals Holdings, Inc.	$8.18M	$0 0.0% of portfolio	200	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.